《異動股》半新股PlattNera(01949.HK)續漲20%再破頂成交增
下周四(22日)放榜的半新股Platt Nera(01949.HK)三連漲,尤其是今天急升再創上市新高,最高見2.51元,較上市價1.25元,已累積飆升1倍,現造2.45元,續漲20%,成交增至876萬股,為掛牌以來第四高,涉資2,056萬元。
Platt Nera為泰國IT企業,主要為當地金融機構、政府部門及機關提供IT解決方案。是次來港上市發售1億股集資淨額9,240萬元,其中公開發售認購一手中籤率僅14%。上市保薦人浩德融資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.